Prevention and control of infectious diseases among people who inject drugs: key recommendations and new evidence within the updated guidance from the ECDC and the EMCDDA

In programme
Wednesday, 23 November, 2022 - 13:20 to 14:50
View presentations

About

Prevention and control of infectious diseases among people who inject drugs: key recommendations and new evidence within the updated guidance from the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The aim of the session is to present the updated ECDC/EMCDDA guidance on the prevention and control of infectious diseases among people who inject drugs. The focus will be on presenting key recommendations from the updated joint guidance as well as the new evidence from systematic reviews behind some of these. The updated joint guidance focuses on the prevention and control of hepatitis B, hepatitis C, HIV/AIDS and tuberculosis (TB) and is intended for use by policy makers and public health/social programme planners. This presentation will cover the key intervention areas and recommendations from the updated guidance. Content for the updated guidance arose through: •An update of the Review of Reviews (RoR) on the effectiveness of needle and syringe programmes (NSP), drug treatment and drug consumption rooms (DCRs) •A literature review of modelling studies on the population level impact of combination of drug treatment and NSP •A desk review of current guidelines related to infectious disease vaccination, testing and treatment •A systematic review of interventions to improve linkage to care and adherence to treatment for the above infectious diseases. The key areas for intervention to prevent and control infectious diseases among people who inject drugs are: sterile injection equipment; drug dependence treatment; drug consumption rooms; vaccination; infectious disease testing; infectious disease treatment; and health promotion. These areas of intervention are considered the key components of a comprehensive approach to prevent and control infectious diseases in this population. They, and the recommendations within them, should be applied in combination to the extent possible.

Chair

Tracks

Keywords